Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diabetes drugs
Marketing
Lilly fends off Novo’s legal bid to block GLP-1 marketing claims
A U.S. judge has ruled Eli Lilly can keep making marketing claims challenged by Novo pending a ruling on a court case brought by the Danish drugmaker.
Nick Paul Taylor
Oct 27, 2026 10:06am
Novo Nordisk opens Czech plant to produce next-gen obesity drugs
Jun 17, 2026 11:22am
Novo's longtime CEO Lars Fruergaard Jørgensen to step down
May 16, 2025 9:41am
As sales soared industrywide in Q3, Pfizer claimed No. 1 spot
Nov 25, 2024 3:00am
Lilly cuts revenue guidance as momentum stalls for tirzepatide
Oct 30, 2024 9:47am
Insulet unveils $200M insulin delivery device production site
Aug 15, 2024 8:34am